RMMS Recognized as Litigation Leader in IAM Patent 1000 – William Rakoczy and Deanne Mazzochi Receive Individual Recognition Awards & Recognition June 10, 2019 Read More
RMMS Recognized Nationally and Regionally for Life Sciences Litigation – William Rakoczy and Paul Molino Selected as IP Stars Awards & Recognition April 2, 2019 Read More
RMMS Files Supreme Court Amicus Brief on Behalf of AAM Challenging The Federal Circuit’s Reading Of The IPR Time Bar Under Section 315(b) CounselingPTAB February 13, 2019 Read More
RMMS Secures Favorable Claim Construction Ruling in NEULASTA® (pegfilgrastim) BPCIA Litigation Biologics November 20, 2018 Read More
Federal Circuit Affirms Invalidity Judgment Concerning COPAXONE® (Glatiramer Acetate) Small Molecules October 12, 2018 Read More
RMMS Recognized as Industry Leaders by LMG Life Sciences for Seventh Consecutive Year Awards & Recognition September 27, 2018 Read More
RMMS Listed as Highly Recommended Patent Firm by Managing IP; William A. Rakoczy and Paul J. Molino Recognized as IP Stars Awards & Recognition June 22, 2018 Read More
RMMS Partner Deanne M. Mazzochi Recognized as a Top Lawyer among Leading Women Lawyers in Illinois by Leading Lawyers Awards & Recognition June 22, 2018 Read More
RMMS Recognized as a Leading Patent Firm in Litigation by IAM Patent 1000; William A. Rakoczy Individually Ranked “Gold” in Litigation by IAM Patent 1000 Awards & Recognition June 22, 2018 Read More
Federal Circuit Affirms Invalidity Judgment Concerning AXIRON® (Testosterone) Transdermal Solution Medical DevicesSmall Molecules November 22, 2017 Read More
RMMS Partner William Rakoczy Recognized by Chambers & Partners Awards & Recognition July 28, 2017 Read More
RMMS Scores Win in Europe Relating to Shire’s Factor VIII ADVATE Franchise Biologics May 16, 2017 Read More
RMMS Named “U.S. Firm to Watch” by Managing Intellectual Property Magazine Awards & Recognition March 23, 2017 Read More
Federal Circuit Affirms Collateral Estoppel Decision Concerning Latisse® (bimatoprost topical solution) Small Molecules March 17, 2017 Read More
RMMS Secures Invalidity Win on Copaxone® 40 (glatiramer acetate 40 mg/mL) Small Molecules January 30, 2017 Read More
RMMS Secures Invalidity And Non-Infringement Victories on Patents Related To Axiron® (Testosterone) Transdermal Solution Medical DevicesSmall Molecules August 22, 2016 Read More
RMMS Recognized As Second Most Active Firm Representing Defendants in Hatch-Waxman Cases Small Molecules April 27, 2016 Read More
Federal Circuit Affirms Judgment of Invalidity Concerning OxyContin® (oxycodone extended-release tablets) Small Molecules February 1, 2016 Read More
RMMS Secures Favorable Claim Construction Ruling In Suit Involving Generic Aripiprazole (Abilify®) Small Molecules November 16, 2015 Read More
RMMS Recognized as Industry Leaders by LMG Life Sciences for Fourth Consecutive Year Awards & Recognition October 20, 2015 Read More